|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006610,
umls-concept:C0032743,
umls-concept:C0040405,
umls-concept:C0205210,
umls-concept:C0205307,
umls-concept:C0220825,
umls-concept:C0278689,
umls-concept:C0441889,
umls-concept:C0542559,
umls-concept:C0750491,
umls-concept:C2347296
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-8-4
|
|
pubmed:abstractText |
This study was conducted to estimate the accuracy of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) as compared with contrast-enhanced CT (CECT) in detecting cancer in patients who have normal cancer antigen (CA)-125 (<35 U/dL) but are suspected of having a recurrent disease based on clinical symptoms.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1525-1438
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
936-44
|
|
pubmed:meshHeading |
pubmed-meshheading:20683399-Adult,
pubmed-meshheading:20683399-Aged,
pubmed-meshheading:20683399-Aged, 80 and over,
pubmed-meshheading:20683399-CA-125 Antigen,
pubmed-meshheading:20683399-Cohort Studies,
pubmed-meshheading:20683399-Female,
pubmed-meshheading:20683399-Fluorodeoxyglucose F18,
pubmed-meshheading:20683399-Humans,
pubmed-meshheading:20683399-Middle Aged,
pubmed-meshheading:20683399-Neoplasm Recurrence, Local,
pubmed-meshheading:20683399-Ovarian Neoplasms,
pubmed-meshheading:20683399-Positron-Emission Tomography,
pubmed-meshheading:20683399-Predictive Value of Tests,
pubmed-meshheading:20683399-Radiopharmaceuticals,
pubmed-meshheading:20683399-Reference Values,
pubmed-meshheading:20683399-Retrospective Studies,
pubmed-meshheading:20683399-Sensitivity and Specificity,
pubmed-meshheading:20683399-Tomography, X-Ray Computed,
pubmed-meshheading:20683399-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
|
|
pubmed:affiliation |
Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. Priya.bhosale@di.mdacc.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|
